$128 Thousand is the total value of Birchview Capital, LP's 55 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 14.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BMY | Buy | BRISTOL-MYERS SQUIBB CO | $50,498 | -3.6% | 728,585 | +0.1% | 39.54% | +6.9% |
| BDSX | BIODESIX INC | $9,374 | -19.1% | 5,039,633 | 0.0% | 7.34% | -10.4% | |
| NBIX | NEUROCRINE BIOSCIENCES INC | $8,527 | -15.3% | 84,240 | 0.0% | 6.68% | -6.1% | |
| PRTA | Buy | PROTHENA CORP PLC | $6,223 | -18.8% | 128,395 | +0.9% | 4.87% | -10.0% |
| QDEL | QUIDELORTHO CORP | $5,462 | +4.0% | 61,306 | 0.0% | 4.28% | +15.3% | |
| ACAD | ACADIA PHARMACEUTICALS INC | $4,694 | +18.2% | 249,400 | 0.0% | 3.68% | +31.1% | |
| HROW | HARROW HEALTH INC | $3,809 | +43.4% | 180,000 | 0.0% | 2.98% | +58.9% | |
| UTHR | UNITED THERAPEUTICS CORP | $3,359 | -19.5% | 15,000 | 0.0% | 2.63% | -10.7% | |
| OVV | OVINTIV INC | $3,038 | -28.9% | 84,200 | 0.0% | 2.38% | -21.1% | |
| MASI | MASIMO CORP | $2,820 | +24.7% | 15,280 | 0.0% | 2.21% | +38.3% | |
| PHR | PHREESIA INC | $2,670 | -0.2% | 82,700 | 0.0% | 2.09% | +10.6% | |
| AZYO | Buy | AZIYO BIOLOGICS INC | $2,499 | -61.2% | 1,655,184 | +9.2% | 1.96% | -57.0% |
| FHTX | FOGHORN THERAPEUTICS INC | $1,642 | -2.8% | 264,843 | 0.0% | 1.29% | +7.7% | |
| AXDX | ACCELERATE DIAGNOSTICS INC | $1,577 | -0.8% | 2,252,388 | 0.0% | 1.24% | +10.0% | |
| ALKS | ALKERMES PLC | $1,410 | +7.9% | 50,000 | 0.0% | 1.10% | +19.6% | |
| INBX | INHIBRX INC | $1,329 | -23.4% | 70,448 | 0.0% | 1.04% | -15.1% | |
| ATEC | Sell | ALPHATEC HOLDINGS INC | $1,248 | +12.2% | 80,000 | -11.1% | 0.98% | +24.5% |
| KPTI | KARYOPHARM THERAPEUTICS INC | $1,133 | +14.3% | 291,332 | 0.0% | 0.89% | +26.7% | |
| CORT | CORCEPT THERAPEUTICS INC | $1,083 | +6.6% | 50,000 | 0.0% | 0.85% | +18.1% | |
| DOCGO INC | $952 | +22.4% | 110,000 | 0.0% | 0.74% | +35.5% | ||
| Buy | VENTYX BIOSCIENCES INC | $884 | +22.6% | 26,400 | +20.0% | 0.69% | +36.0% | |
| CYTK | CYTOKINETICS INC | $880 | -23.2% | 25,000 | 0.0% | 0.69% | -14.9% | |
| PTGX | PROTAGONIST THERAPEUTICS INC | $874 | +110.6% | 38,000 | 0.0% | 0.68% | +133.4% | |
| APLS | APELLIS PHARMACEUTICALS INC | $792 | +27.5% | 12,000 | 0.0% | 0.62% | +41.2% | |
| PXD | PIONEER NATURAL RESOURCES CO | $776 | -10.6% | 3,800 | 0.0% | 0.61% | -0.8% | |
| ETRN | EQUITRANS MIDSTREAM CORPORATIO | $769 | -13.7% | 133,050 | 0.0% | 0.60% | -4.3% | |
| TVTX | New | TRAVERE THERAPEUTICS INC | $675 | – | 30,000 | +100.0% | 0.53% | – |
| BLUE | Buy | BLUEBIRD BIO INC | $633 | -6.6% | 199,200 | +103.3% | 0.50% | +3.5% |
| 2SEVENTY BIO INC | $610 | +8.7% | 59,833 | 0.0% | 0.48% | +20.7% | ||
| ISEE | IVERIC BIO INC | $608 | +13.6% | 25,000 | 0.0% | 0.48% | +25.9% | |
| IMGN | IMMUNOGEN INC | $576 | -22.6% | 150,000 | 0.0% | 0.45% | -14.3% | |
| TXG | 10X GENOMICS INC | $558 | +53.3% | 10,000 | 0.0% | 0.44% | +70.0% | |
| SLNO | SOLENO THERAPEUTICS INC | $525 | +8.2% | 245,127 | 0.0% | 0.41% | +19.8% | |
| ARVN | ARVINAS INC | $410 | -20.1% | 15,000 | 0.0% | 0.32% | -11.3% | |
| SILK | SILK ROAD MEDICAL INC | $391 | -26.1% | 10,000 | 0.0% | 0.31% | -18.2% | |
| HALO | HALOZYME THERAPEUTICS INC | $382 | -32.9% | 10,000 | 0.0% | 0.30% | -25.6% | |
| XENE | XENON PHARMACEUTICALS INC | $358 | -9.1% | 10,000 | 0.0% | 0.28% | +0.7% | |
| KDNY | New | CHINOOK THERAPEUTICS INC | $347 | – | 15,000 | +100.0% | 0.27% | – |
| SRPT | SAREPTA THERAPEUTICS INC | $345 | +6.5% | 2,500 | 0.0% | 0.27% | +17.9% | |
| XNCR | XENCOR INC | $343 | +7.2% | 12,300 | 0.0% | 0.27% | +19.0% | |
| KNSA | KINIKSA PHARMACEUTICALS LTD | $323 | -28.1% | 30,000 | 0.0% | 0.25% | -20.2% | |
| KALV | KALVISTA PHARMACEUTICALS INC | $314 | +16.3% | 40,000 | 0.0% | 0.25% | +28.8% | |
| FOLD | AMICUS THERAPEUTICS INC | $311 | -9.1% | 28,000 | 0.0% | 0.24% | +0.4% | |
| KROS | KEROS THERAPEUTICS INC | $299 | -11.0% | 7,000 | 0.0% | 0.23% | -1.3% | |
| PGNY | New | PROGYNY INC | $289 | – | 9,000 | +100.0% | 0.23% | – |
| CGEM | CULLINAN ONCOLOGY INC | $257 | -3.0% | 25,114 | 0.0% | 0.20% | +7.5% | |
| BCRX | BIOCRYST PHARMACEUTICALS INC | $167 | -27.4% | 20,000 | 0.0% | 0.13% | -19.1% | |
| IFRX | INFLARX NV | $136 | -37.3% | 70,000 | 0.0% | 0.11% | -30.7% | |
| STOK | STOKE THERAPEUTICS INC | $125 | -9.4% | 15,000 | 0.0% | 0.10% | +1.0% | |
| GOSS | GOSSAMER BIO INC | $125 | -41.9% | 99,088 | 0.0% | 0.10% | -35.5% | |
| GTHX | G1 THERAPEUTICS INC | $107 | -50.7% | 40,000 | 0.0% | 0.08% | -45.1% | |
| NKTR | NEKTAR THERAPEUTICS | $83 | -68.9% | 118,000 | 0.0% | 0.06% | -65.6% | |
| YTEN | YIELD10 BIOSCIENCE INC | $52 | +67.7% | 18,750 | 0.0% | 0.04% | +86.4% | |
| ANGN | ANGION BIOMEDICA CORP | $32 | -27.3% | 54,392 | 0.0% | 0.02% | -19.4% | |
| AWH | ASPIRA WOMEN'S HEALTH INC | $22 | +10.0% | 60,070 | 0.0% | 0.02% | +21.4% | |
| SIEN | Exit | SIENTRA INC | $0 | – | -40,000 | -100.0% | -0.01% | – |
| BHVN | Exit | BIOHAVEN PHARMACEUTICAL HOLDING CO LTD | $0 | – | -7,365 | -100.0% | -0.07% | – |
| CNCE | Exit | CONCERT PHARMACEUTICALS INC | $0 | – | -20,000 | -100.0% | -0.08% | – |
| AVEO | Exit | AVEO PHARMACEUTICALS INC | $0 | – | -100,000 | -100.0% | -1.06% | – |
| ALBO | Exit | ALBIREO PHARMA INC | $0 | – | -117,000 | -100.0% | -1.79% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ACCELERATE DIAGNOSTICS INC | 36 | Q3 2023 | 34.6% |
| QUIDELORTHO CORP | 36 | Q3 2023 | 8.6% |
| MASIMO CORP | 36 | Q3 2023 | 2.2% |
| PIONEER NATURAL RESOURCES CO (PXD) | 36 | Q3 2023 | 0.7% |
| XENCOR INC | 35 | Q3 2023 | 0.4% |
| NEUROCRINE BIOSCIENCES INC | 33 | Q3 2023 | 7.4% |
| CORCEPT THERAPEUTICS INC | 32 | Q3 2023 | 1.2% |
| BIOGEN INC | 31 | Q2 2022 | 3.1% |
| CONTRAFECT CORP | 30 | Q3 2022 | 1.6% |
| YIELD10 BIOSCIENCE INC | 26 | Q3 2023 | 0.6% |
View Birchview Capital, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| SOLENO THERAPEUTICS INC | March 19, 2019 | 742,635 | 2.3% |
| YIELD10 BIOSCIENCE, INC. | December 29, 2017 | 186,079 | 2.2% |
| HANSEN MEDICAL INC | February 16, 2016 | ? | ? |
| METABOLIX, INC. | June 23, 2015 | 749,696 | 2.8% |
View Birchview Capital, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 3/A | 2024-02-20 |
| 4/A | 2024-02-20 |
| SC 13G/A | 2024-02-20 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-08 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-04-07 |
| 4 | 2023-03-27 |
| 3 | 2023-02-13 |
View Birchview Capital, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.